[go: up one dir, main page]

AR110913A1 - Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas - Google Patents

Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas

Info

Publication number
AR110913A1
AR110913A1 ARP180100195A ARP180100195A AR110913A1 AR 110913 A1 AR110913 A1 AR 110913A1 AR P180100195 A ARP180100195 A AR P180100195A AR P180100195 A ARP180100195 A AR P180100195A AR 110913 A1 AR110913 A1 AR 110913A1
Authority
AR
Argentina
Prior art keywords
infectious diseases
compound
aminoglucoside
prevent
treat infectious
Prior art date
Application number
ARP180100195A
Other languages
English (en)
Inventor
Masayuki Igarashi
Takashi Ida
Yoshiaki Takahashi
Eijiro Umemura
Original Assignee
Microbial Chem Res Found
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chem Res Found, Meiji Seika Pharma Co Ltd filed Critical Microbial Chem Res Found
Publication of AR110913A1 publication Critical patent/AR110913A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se describe un compuesto representado por la fórmula general (1), o una de sus sales o solvatos farmacéuticamente aceptables, y una composición farmacéutica de esta, y el uso de esta para prevenir o tratar enfermedades infecciosas y un método para prevenir o tratar enfermedades infecciosas usando estos regímenes. El compuesto representado por la fórmula general (1) tiene una actividad antibacteriana contra bacterias grampositivas y gramnegativas, y es útil en la prevención o el tratamiento de enfermedad infecciosas causada por estas bacterias.
ARP180100195A 2017-01-27 2018-01-26 Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas AR110913A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017013030A JP2020055749A (ja) 2017-01-27 2017-01-27 多剤耐性菌に有効な新規アミノグリコシド抗生物質

Publications (1)

Publication Number Publication Date
AR110913A1 true AR110913A1 (es) 2019-05-15

Family

ID=62979533

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100195A AR110913A1 (es) 2017-01-27 2018-01-26 Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas

Country Status (4)

Country Link
JP (1) JP2020055749A (es)
AR (1) AR110913A1 (es)
TW (1) TW201839005A (es)
WO (1) WO2018139599A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021138615A (ja) * 2018-05-31 2021-09-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 多剤耐性菌に有効なアミノグリコシド抗生物質の製造方法
CN116462721B (zh) * 2023-04-18 2024-02-02 江南大学 抗菌性氨基糖苷衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4360665A (en) * 1981-12-24 1982-11-23 Eli Lilly And Company 4"-N-(Substituted)-apramycin antibiotic derivatives and intermediates therefor
CN103228282A (zh) * 2010-09-13 2013-07-31 苏黎世大学 细菌感染性疾病的治疗
MX383996B (es) * 2015-07-30 2025-03-14 Microbial Chem Res Found Antibiótico aminoglucósido novedoso efectivo contra bacterias resistentes a múltiples fármacos.

Also Published As

Publication number Publication date
JP2020055749A (ja) 2020-04-09
TW201839005A (zh) 2018-11-01
WO2018139599A1 (ja) 2018-08-02

Similar Documents

Publication Publication Date Title
MX373444B (es) Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas.
BR112018005318A2 (pt) ?polipeptídeos de lisina ativos contra bactérias gram-negativas?
CR20200148A (es) Compuestos monobactámicos cromados para el tratamiento de infecciones bacterianas
MX384234B (es) Uso de pridopidina para el tratamiento de enfermedad de huntington.
MX385731B (es) Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas.
AR101740A1 (es) Terapia de combinación y composiciones
EA201990551A1 (ru) Антибиотические соединения
MX2020003593A (es) Compuestos de benzotiazol y metodos para usar los mismos para tratar trastornos neurodegenerativos.
CO2018001237A2 (es) Derivados de apramicina efectivos contra bacterias resistentes a múltiples fármacos y composiciones de los mismos
CL2020001147A1 (es) Compuestos antibacterianos
CL2019000857A1 (es) Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas.
MX389771B (es) Compuestos de minociclina para biodefensas.
MX385203B (es) Compuestos y métodos para tratar infecciones bacterianas.
MX2022011203A (es) Compuestos de 9-aminometil minociclina y usos de los mismos.
EA201890412A1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
BR112019024549A2 (pt) compostos derivados de glicopeptídeo e usos dos mesmos
PE20181450A1 (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
AR110913A1 (es) Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas
BR112017016278A2 (pt) agente preventivo e/ou terapêutico de doença imune
MX373098B (es) Derivados de manosa para tratar infecciones bacterianas.
MX2021012146A (es) Formulacion de tableta vaginal.
BR112023019720A2 (pt) Uso de análogos de rifamicina em combinação com vancomicina, composição farmacêutica compreendendo esses compostos, método in vitro para prevenir ou inibir o crescimento de uma bactéria e kit
BR112018002138A2 (pt) composto 2-(5 s-metil-2-oxo-4r-fenil-pirrolidin-1-il)-acetamida, uso, composição farmacêutica e método para a profilaxia ou o tratamento de convulsões
BR112019014738A8 (pt) Composto, forma de dosagem sólida, composição farmacêutica, forma cristalina de composto, método para tratar infecção por hepatite c ou uma condição resultante de uma infecção por hepatite c, composto da fórmula, e, uso de um composto da fórmula
JO3477B1 (ar) مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية

Legal Events

Date Code Title Description
FB Suspension of granting procedure